Latest Insider Transactions at Galectin Therapeutics Inc (GALT)
This section provides a real-time view of insider transactions for Galectin Therapeutics Inc (GALT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GALECTIN THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GALECTIN THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 23
2025
|
Kary Eldred |
BUY
Open market or private purchase
|
Direct |
1,400
+1.06%
|
$4,200
$3.73 P/Share
|
|
Dec 23
2025
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Direct |
5,500
+9.05%
|
$16,500
$3.55 P/Share
|
|
Dec 17
2025
|
Harold H. Shlevin |
SELL
Open market or private sale
|
Direct |
24,499
-52.92%
|
$171,493
$7.04 P/Share
|
|
Dec 17
2025
|
Harold H. Shlevin |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+39.06%
|
$20,000
$1.98 P/Share
|
|
Dec 17
2025
|
Khurram Jamil Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
19,442
-100.0%
|
$136,094
$7.04 P/Share
|
|
Dec 17
2025
|
Khurram Jamil Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,963
+50.0%
|
$29,926
$2.35 P/Share
|
|
Dec 17
2025
|
Joel Lewis President and CEO |
SELL
Open market or private sale
|
Direct |
7,829
-0.93%
|
$54,803
$7.06 P/Share
|
|
Dec 17
2025
|
Joel Lewis President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,829
+0.92%
|
$15,658
$2.86 P/Share
|
|
Dec 16
2025
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,681
-0.54%
|
$184,086
$6.66 P/Share
|
|
Dec 15
2025
|
Harold H. Shlevin |
SELL
Open market or private sale
|
Direct |
8,417
-42.89%
|
$50,502
$6.3 P/Share
|
|
Dec 15
2025
|
Harold H. Shlevin |
BUY
Exercise of conversion of derivative security
|
Direct |
8,417
+30.02%
|
$33,668
$4.16 P/Share
|
|
Dec 12
2025
|
Harold H. Shlevin |
SELL
Open market or private sale
|
Direct |
19,793
-63.85%
|
$118,758
$6.27 P/Share
|
|
Dec 12
2025
|
Harold H. Shlevin |
BUY
Exercise of conversion of derivative security
|
Direct |
19,793
+38.97%
|
$79,172
$4.16 P/Share
|
|
Dec 09
2025
|
Harold H. Shlevin |
SELL
Open market or private sale
|
Direct |
16,790
-59.97%
|
$100,740
$6.27 P/Share
|
|
Dec 09
2025
|
Harold H. Shlevin |
BUY
Exercise of conversion of derivative security
|
Direct |
16,790
+37.49%
|
$67,160
$4.16 P/Share
|
|
Dec 08
2025
|
Harold H. Shlevin |
SELL
Open market or private sale
|
Direct |
159,000
-62.73%
|
$795,000
$5.98 P/Share
|
|
Dec 08
2025
|
Harold H. Shlevin |
BUY
Exercise of conversion of derivative security
|
Direct |
155,000
+40.7%
|
$155,000
$1.98 P/Share
|
|
Dec 03
2025
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
120,000
-2.07%
|
$600,000
$5.73 P/Share
|
|
Dec 02
2025
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,000
-0.51%
|
$150,000
$5.47 P/Share
|
|
Nov 24
2025
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
24,000
-0.42%
|
-
|
|
Nov 18
2025
|
Jack W Callicutt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
46,310
-74.6%
|
$277,860
$6.22 P/Share
|
|
Nov 18
2025
|
Jack W Callicutt Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
46,310
+42.69%
|
$46,310
$1.55 P/Share
|
|
Nov 18
2025
|
Joel Lewis President and CEO |
SELL
Open market or private sale
|
Direct |
6,783
-0.81%
|
$40,698
$6.15 P/Share
|
|
Nov 18
2025
|
Joel Lewis President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,783
+0.8%
|
$13,566
$2.39 P/Share
|
|
Nov 17
2025
|
Jack W Callicutt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
31,610
-50.41%
|
$189,660
$6.03 P/Share
|
|
Nov 17
2025
|
Jack W Callicutt Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
31,610
+32.21%
|
$31,610
$1.44 P/Share
|
|
Nov 17
2025
|
Joel Lewis President and CEO |
SELL
Open market or private sale
|
Direct |
15,680
-1.85%
|
$94,080
$6.04 P/Share
|
|
Nov 17
2025
|
Joel Lewis President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,680
+1.81%
|
$31,360
$2.39 P/Share
|
|
Nov 13
2025
|
Khurram Jamil Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
121,117
-85.48%
|
$605,585
$5.47 P/Share
|
|
Nov 13
2025
|
Khurram Jamil Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
99,250
+46.27%
|
$99,250
$1.98 P/Share
|
|
Nov 11
2025
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
40,000
-0.68%
|
$200,000
$5.25 P/Share
|
|
Nov 10
2025
|
Jack W Callicutt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,291
-18.8%
|
$31,746
$6.03 P/Share
|
|
Nov 10
2025
|
Jack W Callicutt Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,291
+15.73%
|
$5,291
$1.44 P/Share
|
|
Nov 10
2025
|
Joel Lewis President and CEO |
SELL
Open market or private sale
|
Direct |
1,867
-0.22%
|
$11,202
$6.03 P/Share
|
|
Nov 10
2025
|
Joel Lewis President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,867
+0.22%
|
$3,734
$2.39 P/Share
|
|
Nov 05
2025
|
Joel Lewis President and CEO |
SELL
Open market or private sale
|
Direct |
200
-0.02%
|
$1,200
$6.0 P/Share
|
|
Nov 05
2025
|
Joel Lewis President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+0.02%
|
$400
$2.39 P/Share
|
|
Nov 05
2025
|
Jack W Callicutt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
600
-2.56%
|
$3,600
$6.0 P/Share
|
|
Nov 05
2025
|
Jack W Callicutt Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+2.5%
|
$600
$1.6 P/Share
|
|
Nov 04
2025
|
Jack W Callicutt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
28,629
-55.52%
|
$171,774
$6.07 P/Share
|
|
Nov 04
2025
|
Jack W Callicutt Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,629
+35.69%
|
$28,629
$1.6 P/Share
|
|
Nov 04
2025
|
Joel Lewis President and CEO |
SELL
Open market or private sale
|
Direct |
14,420
-1.7%
|
$86,520
$6.07 P/Share
|
|
Nov 04
2025
|
Joel Lewis President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,420
+1.67%
|
$28,840
$2.39 P/Share
|
|
Nov 03
2025
|
Jack W Callicutt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,250
-14.1%
|
$7,500
$6.01 P/Share
|
|
Nov 03
2025
|
Jack W Callicutt Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,810
+12.51%
|
$3,810
$1.6 P/Share
|
|
Nov 03
2025
|
Jack W Callicutt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,560
-14.39%
|
$15,360
$6.01 P/Share
|
|
Nov 03
2025
|
Joel Lewis President and CEO |
SELL
Open market or private sale
|
Direct |
1,300
-0.16%
|
$7,800
$6.01 P/Share
|
|
Nov 03
2025
|
Joel Lewis President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+0.16%
|
$2,600
$2.39 P/Share
|
|
Oct 22
2025
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
50,000
-0.42%
|
$200,000
$4.94 P/Share
|
|
Sep 12
2025
|
Joel Lewis President and CEO |
SELL
Open market or private sale
|
Direct |
14,000
-1.65%
|
$84,000
$6.36 P/Share
|